IL-6 switches the differentiation of monocytes from dendritic cells to macrophages

Steinman, R. M. The dendritic cell system and its role in immunogenicity. Annu. Rev. Immunol. 9, 271–296 (1991).

Banchereau, J. & Steinman, R. M. Dendritic cells and the control of immunity. Nature 392, 245–252 (1998).

Banchereau, J. et al. Immunobiology of dendritic cells. Ann. Rev. Immunol. 8, 767–811 (2000).

Becker, S., Warren, M. K. & Haskill, S. Colony-stimulating factor-induced monocyte survival and differentiation into macrophages in serum-free cultures. J. Immunol. 139, 3703–3709 (1987).

Romani, N. et al. Proliferating dendritic cell progenitors in human blood. J. Exp. Med. 180, 83–93 (1994).

Sallusto, F. & Lanzavecchia, A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor α. J. Exp. Med. 179, 1109–1118 (1994).

Zhou, L. J. & Tedder, T. F. CD14+ blood monocytes can differentiate into functionally mature CD83+ dendritic cells. Proc. Natl Acad. Sci. USA 93, 2588–2592 (1996).

Palucka, K. A., Taquet, N., Sanchez-Chapuis, F. & Gluckman, J. C. Dendritic cells as the terminal stage of monocyte differentiation. J. Immunol. 160, 4587–4595 (1998).

Randolph, G. J., Beaulieu, S., Lebecque, S., Steinman, R. M. & Muller, W. A. Differentiation of monocytes into dendritic cells in a model of transendothelial trafficking. Science 282, 480–483 (1998).

Mekori, Y. A. & Metcalfe, D. D. Mast cells in innate immunity. Immunol. Rev. 173, 131–140 (2000).

Yamasaki, K. et al. Cloning and expression of the human interleukin-6 (BSF-2/IFN-β2) receptor. Science 241, 825–828 (1988).

Hibi, M. et al. Molecular cloning and expression of an IL-6 signal transducer, gp130. Cell. 63, 1149–1157 (1990).

Peters, M. et al. The function of the soluble interleukin 6 (IL-6) receptor in vivo: sensitization of human soluble IL-6 receptor transgenic mice towards IL-6 and prolongation of the half-life of IL-6. J. Exp. Med. 183, 1399–1406 (1996).

Menetrier-Caux, C. et al. Inhibition of the differentiation of dendritic cells from CD34+ progenitors by tumor cells: role of interleukin-6 and macrophage colony-stimulating factor. Blood 92, 4778–4791 (1998).

Mitani, H. et al. Activity of interleukin 6 in the differentiation of monocytes to macrophages and dendritic cells. Br. J. Haematol. 109, 288–295 (2000).

Kopf, M. et al. Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature 368, 339–342 (1994).

Ladel, C.H. et al. Lethal tuberculosis in interleukin-6-deficient mutant mice. Infect. Immun. 65, 4843–4849 (1997).

Tanaka, T. et al. Targeted disruption of the NF-IL6 gene disclosed its essential role in bacteria killing and tumor cytotoxicity by macrophages. Cell 80, 353–361 (1995).